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Mentor: Robert Schwartz M.D. 
Problem identification: Colonoscopy is considered the most accurate 
screening test for colorectal cancer. Despite favorable evidence, 
publicity and funding, many patients refuse colonoscopy. 
• This project aimed to investigate the reasons why patients 
refuse colonoscopy, the screening rates for colonoscopy, 
alternatives to colonoscopy and methods primary care 
physicians can use to encourage patients to have colorectal 
cancer screening. 
Description of need: Colorectal cancer is second in both cancer 
incidence and mortality in Vermont3. Despite its presence, screening for 
colorectal cancer remains underused1. Nationally, only 59% of adults 
over 50 have been screened for colorectal cancer2. 
Efforts to increase rates of screening should focus on the primary care 
setting, both provider and patient, where most referrals for colonoscopy 
are made.
Figure 1: CRC Incidence per 100,000 Figure 2: CRC Mortality per 100,000
Cancer type U.S. Vermont
1. Lung and 
Bronchus
61.9 66.8
2. Colorectal 40.6 37.4
3. Melanoma 20.1 33.6
Cancer type U.S. Vermont
1. Lung and 
Bronchus
46.0 47.9
2. Colorectal 15.1 14.5
3. Pancreas 10.9 11.7
Public health cost:
• Colorectal cancer is the second-leading cancer in terms of both incidence 
and mortality in Vermont. 
• Studies suggest that colorectal cancer screening is cost-effective. Less than 
$30,000 must be spent per additional year of life gained. It has been 
estimated that routine screening could save 18,800 lives per year. 
Community perspective on colonoscopy:
Reasons cited for refusal:
“I don’t know what happened but [the colonoscopy] didn’t go well for someone I know.”
-BB (patient)
“I heard the prep is really unpleasant.”
-RM (patient)
“I don’t have insurance so I can’t afford a colonoscopy.”
-MP (patient)
“The idea of being sedated makes me really nervous. I think it’s just my hemorrhoids”
-AS (patient)
Expert perspective:
“Patients usually refuse colonoscopy because of fear of unknown, bad experiences of 
previous friends or relatives. The key is the presentation.”
M.D. – name withheld 
Project intervention and methodology: 
1. Analyzed rates of colonoscopy screening in in Chester, the 
Springfield Medical System, Windsor county, Vermont and the United 
States.
2. Reviewed literature on colorectal cancer screening methods1.
3. Reviewed literature on best practices for getting patients screened in 
the primary care setting4,5. 
4. Created colorectal cancer screening review presentation for the staff 
of Chester Family Medicine incorporating most recent 
recommendations. 
5. Presented for the group on my last day of the clerkship. 
Results/Data:
*These internal Springfield Medical System data only include screening by colonoscopy.
What we can do to increase screening for colorectal cancer: 
Using colloquial language, accessible numeracy, loss-framed and gain-framed 
messages and completeness, providers are recommended6 to address: 
• Probability of developing the cancer
• Operating characteristics of the screening test
• Likelihood screening will benefit the patient
• Potential burdens of the test
Region















Effectiveness of response and limitations:
• My presentation was attended by the 15-person staff of Chester 
Family Medicine and a Springfield Medical Systems executive.
• A discussion followed that built upon the information I presented and 
suggested that the staff was interested in screening more patients in 
the future. 
• Multiple staff members commented that they plan to change their 
practices based on the information presented. 
• The Springfield Medical Systems executive who attended explained 
for the group that for patients without insurance, there is an 
assistance program available that will pay for colonoscopy and other 
procedures completely.   
• There was insufficient time to follow up on how many patients were 
screened after my presentation.
Recommendations for the future:
• Studies have shown that Personal Risk Communication can increase 
patient uptake of screening tests6.  Therefore, rapid, point-of-care 
calculation of a patient’s lifetime risk for colorectal cancer would be 
an invaluable tool for primary care physicians. 
• Currently there is no smart phone app available to calculate a 
patient’s risk of colorectal cancer. Implementation of a smart phone 
app with this capability app would take advantage of Personal Risk 
Communication and give primary care physicians a new and much-
needed tool. 
• A rendering that incorporates some well-proven risk factors for 
colorectal cancer is shown in the image at right. 
Figure Colorectal cancer risk 
assessment app prototype
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